- Investing Ideas
- Canadian Pharmaceuticals & Biotech Mid-Large Cap Stocks
Canadian Pharmaceuticals & Biotech Mid-Large Cap Stocks
Results
4
0 new
Mid-Large Cap Stocks
4 companies
Curaleaf Holdings
Market Cap: CA$3.4b
Engages in the retail and wholesale of cannabis products in the United States and internationally.
CURA
CA$12.63
7D
-3.2%
1Y
105.4%
Cronos Group
Market Cap: CA$1.5b
A cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally.
CRON
CA$4.06
7D
2.8%
1Y
43.5%
Apotex Health
Market Cap: CA$8.2b
Operates as a pharmaceutical manufacturing company in Canada, the United States, Mexico, and India.
APTX
CA$35.76
7D
-4.7%
1Y
n/a
Green Thumb Industries
Market Cap: CA$2.2b
Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.
GTII
CA$10.00
7D
0%
1Y
15.7%